Nu Skin Enterprises, Inc.【NUS】 業績推移・財務諸表

(単位:千ドル) 3Q10 2Q11 3Q11 4Q11 2Q12 3Q12 4Q12 1Q13 2Q13 3Q13 4Q13 1Q14 2Q14 3Q14 4Q14 1Q15 2Q15 3Q15 4Q15 1Q16 2Q16 3Q16 1Q17 2Q17 3Q17 1Q18 2Q18 3Q18 1Q19 2Q19 3Q19 1Q20 2Q20 3Q20 1Q21 2Q21 3Q21 1Q22 2Q22 3Q22 1Q23 2Q23 3Q23 1Q24 2Q24 3Q24 1Q25 2Q25
売上高 - - - - - - - - - - - - - - - - - - - - 600,475 604,162 499,099 550,101 563,698 616,219 704,190 675,312 623,623 623,500 589,934 518,028 612,366 703,347 677,026 704,055 641,152 604,899 560,615 537,805 481,462 500,257 498,772 417,306 439,081 430,145 364,490 386,138
売上成長率(%) - - - - - - - - - - - - - - - - - - - - - - -
売上原価 68,755 71,168 70,631 - 95,584 86,768 - 90,045 111,273 139,816 - 106,644 156,010 109,275 - 105,055 110,263 152,755 - 137,869 128,205 125,863 111,266 121,521 120,832 146,281 168,549 157,457 146,664 154,028 140,162 125,793 154,110 183,374 170,566 171,975 158,907 161,499 148,100 173,500 133,588 135,542 206,505 123,242 131,904 128,682 117,529 120,405
売上総利益 314,798 353,258 357,785 415 497,651 439,414 493,200 460,049 571,654 787,796 891,100 564,417 494,017 529,525 503,100 438,277 449,946 418,553 450,800 333,962 472,270 478,299 387,833 428,580 442,866 469,938 535,641 517,855 476,959 469,472 449,772 392,235 458,256 519,973 506,460 532,080 482,245 443,400 412,515 364,305 347,874 364,715 292,267 294,064 307,177 301,463 246,961 265,733
売上総利益率(%) - - - - - - - - - - - - - - - - - - - -
営業費用 261,903 287,212 290,572 - 399,739 357,047 - 377,390 457,071 619,521 - 463,220 439,280 424,569 - 369,631 378,145 376,012 - 325,813 392,472 395,925 341,571 363,841 378,504 410,948 452,877 437,180 408,306 395,270 379,880 355,670 400,182 445,745 443,547 446,704 416,861 391,255 360,988 384,589 331,810 322,209 318,632 285,242 432,734 283,232 256,864 234,953
営業利益 52,895 66,046 67,213 75 97,912 82,367 88,900 82,659 114,583 168,275 188,600 101,197 54,737 104,956 91,300 68,646 71,801 42,541 61,700 8,149 79,798 82,374 46,262 64,739 64,362 58,990 82,764 80,675 68,653 74,202 69,892 36,565 58,074 74,228 62,913 85,376 65,384 52,145 51,527 -20,284 16,064 42,506 -26,365 8,822 -125,557 18,231 -9,903 30,780
営業利益率 (%) - - - - - - - - - - - - - - - - - - - -
経常(税引前)利益 52,221 65,919 60,334 - 94,543 83,606 - 82,771 113,396 168,779 - 97,593 33,618 106,029 - 56,378 69,043 28,113 - 5,286 68,738 76,679 41,695 62,008 63,190 60,197 71,599 73,693 65,805 70,876 64,913 30,391 59,655 74,753 64,495 81,364 68,165 50,692 42,887 -28,964 14,588 37,113 -34,451 1,101 -131,648 13,298 134,601 27,411
経常(税引前)利益率(%) - - - - - - - - - - - - - - - - - - - - 11.45 12.69 8.35 11.27 11.21 9.77 10.17 10.91 10.55 11.37 11.0 5.87 9.74 10.63 9.53 11.56 10.63 8.38 7.65 -5.39 3.03 7.42 -6.91 0.26 -29.98 3.09 36.93 7.1
法人税等合計 16,932 24,218 13,536 - 34,136 29,430 - 28,489 38,961 57,879 - 33,332 14,111 37,721 - 20,096 24,386 11,846 - 1,970 24,025 19,807 14,206 19,967 21,518 24,658 20,638 20,547 22,803 24,500 20,800 10,700 17,800 18,400 17,100 22,000 18,400 12,000 8,700 -3,600 3,200 10,200 2,500 1,600 -13,400 5,000 27,100 6,300
実効税率(%) - - - - -
純利益 35,289 41,701 46,798 49 60,407 54,176 59,200 54,282 74,435 110,900 125,300 64,261 19,507 68,308 46,500 36,282 44,657 16,267 35,800 3,316 44,713 56,872 27,489 42,041 41,672 35,539 50,961 53,146 43,002 46,349 44,090 19,730 41,851 56,307 47,430 59,338 49,729 38,716 34,237 -25,390 11,376 26,892 -36,955 -533 -118,258 8,302 107,515 21,119
純利益率(%) - - - - - - - - - - - - - - - - - - - -
一株あたり利益 0.57 0.67 0.75 0.8 0.98 0.91 1.01 0.93 1.27 1.89 2.13 1.09 0.33 1.15 0.79 0.62 0.76 0.28 0.63 0.06 0.8 1.02 0.52 0.79 0.79 0.66 0.92 0.96 0.78 0.83 0.79 0.36 0.81 1.1 0.94 1.18 0.99 0.77 0.68 -0.51 0.23 0.54 -0.74 -0.01 -2.38 0.17 2.16 0.43
希薄化後一株あたり利益 0.55 0.65 0.72 0.76 0.94 0.87 0.97 0.9 1.22 1.8 2.02 1.05 0.32 1.12 0.77 0.6 0.75 0.28 0.62 0.06 0.79 0.98 0.51 0.77 0.76 0.64 0.9 0.94 0.77 0.83 0.79 0.36 0.81 1.08 0.91 1.15 0.97 0.76 0.67 -0.51 0.23 0.54 -0.74 -0.01 -2.38 0.17 2.14 0.43
一株あたり配当金 - - 0.16 - - 0.2 - 0.3 0.3 0.3 - 0.34 0.34 - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
EBITDA - - - - - - - - - - - - - - - - - -
EBITDAマージン(%) - - - - - - - - - - - - - - - - - - - - - -